These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12227681)

  • 1. Oxidative stress and TGFbeta in kidney-transplanted patients with cyclosporin-induced hypertension. Effect of carvedilol and nifedipine.
    Calò L; Giacon B; Davis PA; Pagnin E; Piccin A; Riegler P; Huber W; Antonello A; Semplicini A
    Clin Nephrol; 2002 Aug; 58(2):103-10. PubMed ID: 12227681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arterial hypertension and oxidative stress induced by cyclosporin. Effect of carvedilol].
    Pagnin E; Giacon B; Zaghetto F; Vianello D; Bonfante L; Huber W; Antonello A; Semplicini A; Calò L
    Ann Ital Med Int; 2001; 16(2):101-5. PubMed ID: 11688356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of carvedilol and nebivolol on oxidative stress-related parameters and endothelial function in patients with essential hypertension.
    Zepeda RJ; Castillo R; Rodrigo R; Prieto JC; Aramburu I; Brugere S; Galdames K; Noriega V; Miranda HF
    Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):309-16. PubMed ID: 22703478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress in kidney transplant patients with calcineurin inhibitor-induced hypertension: effect of ramipril.
    Calò LA; Davis PA; Giacon B; Pagnin E; Sartori M; Riegler P; Antonello A; Huber W; Semplicini A
    J Cardiovasc Pharmacol; 2002 Oct; 40(4):625-31. PubMed ID: 12352326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nifedipine versus carvedilol in the treatment of de novo arterial hypertension after liver transplantation: results of a controlled clinical trial.
    Galioto A; Semplicini A; Zanus G; Fasolato S; Sticca A; Boccagni P; Frigo AC; Cillo U; Gatta A; Angeli P
    Liver Transpl; 2008 Jul; 14(7):1020-8. PubMed ID: 18581464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin-induced endothelial dysfunction and hypertension: are nitric oxide system abnormality and oxidative stress involved?
    Calò L; Semplicini A; Davis PA; Bonvicini P; Cantaro S; Rigotti P; D'Angelo A; Livi U; Antonello A
    Transpl Int; 2000; 13 Suppl 1():S413-8. PubMed ID: 11112045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus.
    Albergati F; Paternó E; Venuti RP; Boeri D; Lombardo I; Semino S; Viviani GL; Adezati L
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S86-9. PubMed ID: 1378156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of carvedilol on oxidative stress in polymorphonuclear and mononuclear cells in patients with essential hypertension.
    Yasunari K; Maeda K; Nakamura M; Watanabe T; Yoshikawa J; Asada A
    Am J Med; 2004 Apr; 116(7):460-5. PubMed ID: 15047035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol inhibits aortic lipid deposition in the hypercholesterolemic rat.
    Feuerstein GZ; Fisher M; Nunnart J; Ruffolo RR
    Pharmacology; 1997 Jan; 54(1):24-32. PubMed ID: 9065958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress in chronic renal allograft nephropathy in rats: effects of long-term treatment with carvedilol, BM 91.0228, or alpha-tocopherol.
    Göttmann U; Oltersdorf J; Schaub M; Knoll T; Back WE; van der Woude FJ; Braun C
    J Cardiovasc Pharmacol; 2003 Sep; 42(3):442-50. PubMed ID: 12960691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of beta-blocker use on cyclosporine level in cardiac transplant recipients.
    Bader FM; Hagan ME; Crompton JA; Gilbert EM
    J Heart Lung Transplant; 2005 Dec; 24(12):2144-7. PubMed ID: 16364863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between nifedipine and carvedilol in the treatment of de novo arterial hypertension after liver transplantation: preliminary results of a controlled clinical trial.
    Galioto A; Angeli P; Guarda S; Burra P; Zanus G; Fasolato S; Fagiuoli S; Sticca A; Semplicini A; Sartori M; Carraro A; Boccagni P; Cillo U; Gatta A
    Transplant Proc; 2005 Mar; 37(2):1245-7. PubMed ID: 15848684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of the coadministration of carvedilol and nifedipine sustained-release in the treatment of essential hypertension.
    Juttmann JR; de Vries Robles P; Venuti RP
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S134-7. PubMed ID: 1378141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of antioxidant property of carvedilol in mild to moderate hypertensive patients: A prospective open-label study.
    Ayashi S; Assareh AR; Jalali MT; Olapour S; Yaghooti H
    Indian J Pharmacol; 2016; 48(4):372-376. PubMed ID: 27756946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of carvedilol compared to nifedipine in the treatment of mild and moderate essential arterial hypertension].
    Plavnik FL; Freitas AF; Portela JE; Dantas M; Spritzer T; Kohlmann NE; Spritzer N; Furtado MR; Kohlmann O
    Arq Bras Cardiol; 1994 Nov; 63(5):405-8. PubMed ID: 7611920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of carvedilol, slow-release nifedipine, and atenolol in the management of essential hypertension.
    Hall S; Prescott RI; Hallman RJ; Dixon S; Harvey RE; Ball SG
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S35-8. PubMed ID: 1721977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.
    Giugliano D; Marfella R; Acampora R; Giunta R; Coppola L; D'Onofrio F
    Diabetes Care; 1998 Apr; 21(4):631-6. PubMed ID: 9571355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
    Deetjen A; Heidland A; Pangerl A; Meyer-Sabellek W; Schaefer RM
    Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of cyclosporin A blood levels during carvedilol treatment in renal transplant patients.
    Kaijser M; Johnsson C; Zezina L; Backman U; Dimény E; Fellström B
    Clin Transplant; 1997 Dec; 11(6):577-81. PubMed ID: 9408688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.